Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-607-2 | CAS number: 993-13-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: LD50 (male/female) rat: 1888 mg/kg bw; LD50 (female) rat:1760 mg/kg bw; LD50 (male) rat: 2005 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Charles River Laboratories, Wilmington, MA
- Age at study initiation: about 7 weeks
- Weight at study initiation: 150 to 225 g
- Fasting period before study: over night
- Housing: individually, steel wire mesh cages
- Diet ad libitum
- Water ad libitum
- Acclimation period: yes
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-26 °C
- Humidity (%): 30-70 %
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 2000, 1750, 1500, 1000 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: prior to dosing
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, organ weights, histopathology - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 888 mg/kg bw
- 95% CL:
- 1 462 - 2 438
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 005 mg/kg bw
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 760 mg/kg bw
- Mortality:
- At 2000 mg/kg bw all deaths occurred on day 1 of the study. At 1750 mg/kg bw, one female died on day 3, one male on day 2.
No adverse clinical signs were seen in any other dose groups.
2000 mg/kg bw: 4/5 males, 5/5 females (9/10)
1750 mg/kg bw: 1/5 males, 1/5 females (2/10)
1500 mg/kg bw 0/5 males, 0/5 females (0/10)
1000 mg/kg bw 0/5 males, 0/5 females (0/10)
0 mg/kg bw 0/5 males, 0/5 females (0/10) - Clinical signs:
- other: At 2000 mg/kg bw, four males and five females were hypoactive and cold to touch with laboured breathing. In addition, three males and two females were observed with convulsions and one male was observed with tremors and redness around nose/eyes.
- Gross pathology:
- Upon necropsy, all animals treated with 2000 mg/kg bw had at lease one gross lesion noted, including a dilated stomach, (4 m/ 2 f), a dilated small and large intestine (3 m/ 3 f) kidney foci (1 m/ 1 f) and enlarged stomach (3 f). At 1750 mg/kg bw 4 m and 2 f had no gross lesions, 1 m had dilated stomach and dilated intestine filled with yellow liquid. Two females had pigmented ovaries and 1 f had a dilated thin-walled stomach filled with fluid and mucosa. as well as a tan liver focus. Ovary pigmentation was observed in 2 f that had not died and in the male that died the stomach was dilated and fluid-filled, with a thin wall , mucus covering and black pigment. The small intestine was dilated and filled with yellow fluid and the liver exhibited a tan lateral lobe focus. At 1500 mg/kg, one female had bilateral red ovary pigmentation. At 1000 mg/kg no gross lesions were observed.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- LD50 was determined to be 1888 mg/kg bw (females: 1760 mg/kg bw; males: 2005 mg/kg bw).
- Executive summary:
The acute oral toxicity of methylphosphonic acid was evaluated in a study conducted according to guideline EPA.OPPTS 870. 1100. For each treatment group 5 males and five females were randomly assigned to treatment and control groups. Animals were administered the test article or vehicle control via oral gavage following an overnight fasting period. The following doses were used: 2000, 1750, 1500, 1000 mg/kg bw. At 2000 mg/kg bw all deaths occurred on day 1 of the study. At 1750 mg/kg bw, one female died on day 3, one male on day 2. No deaths occurred in any other dose groups. Based on the findings of the study, the LD50 was determined to be 1888 mg/kg bw (females: 1760 mg/kg bw; males: 2005 mg/kg bw).
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 888 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because the substance is classified as corrosive to the skin
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because the substance is classified as corrosive to the skin
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity:
Acute oral toxicity of MPA has been investigated by a number of laboratories, since MPA is used as a tracer for the use of chemical warfare agents (CWAs). Unfortunately, a number of study reports done by the U.S. Army are not public available, but the results of the studies have been reviewed by a number of authors discussing the problems associated with CWAs. The study report chosen as key study is the only one dealing with MPA and providing sufficient information to assess the acute toxicity of the chemical. The study identified an overall lethal dose (LD50) in the rat of 1888 mg/kg bw. Clinical signs observed and lesions noted at necropsy are in line with signs of toxicity and lesions observed frequently after acute toxic ingestion of chemicals in the rat. Most lesions are associated with digestive organs the stomach, the intestine and the liver as the primary organ of detoxification. Additionally to these study reports two results of acute oral toxicity studies have been cited in literature, one demonstrating an acute oral toxicity to the rat of >2000 mg/kg bw (Finlay 2004) and one demonstrating an LD50 value of >5000 mg/kg bw in the rat and the mouse Williams 1987). None of these study reports are currently available and experimental details are not provided by the authors of the review (Munro et al.).
Acute inhalation toxicity:
According to Regulation (EC) No. 1907/2006, Column 2 Adaptation to the Column 1, 8.5, the acute toxicity study is not needed to be conducted if the substance is classified as corrosive to the skin. MPA has been classified as corrosive owing to its pH of 0.9 (70% aqueous solution). Further, MPA is relatively non-volatile substance (MPA melts at 105 °C and vapour pressure 0.000267 Pa), hence exposure via inhalation will be low. Also, MPA is highly soluble in water, hence if inhaled may get cleared by mucociliary mechanism of respiratory tract, thereby further reducing the absorption. Taking into consideration above arguments, low toxicity is expected for inhalation exposure of MPA and the acute inhalation toxicity study is considered to be scientifically not necessary.
Acute dermal toxicity:
According to Regulation (EC) No. 1907/2006, Column 2 Adaptation to the Column 1, 8.5, the acute toxicity study is not needed to be conducted if the substance is classified as corrosive to the skin. Dermal penetration studies with a substance containing about 50 % of MPA demonstrated no significant uptake through the skin. Taking the corrosive properties of the test substance into account, moderate to strong irritating or corrosive effects to the skin would be the major sign of toxicity upon dermal exposure to the test substance. The transdermal uptake of the test substance through exposed skin areas is considered to be not sufficient to reach toxic levels of the chemical in the body. Therefore, testing for acute dermal toxicity is considered to be scientifically not necessary. Appropriate labelling of the test substance for acute dermal effects is not considered since labelling for acute oral toxicity as well as for corrosive effects is sufficient to communicate the toxic effects of the substance.
Justification for classification or non-classification
Based on the data provided by Watson et al. (2007), the substance needs to be classified as slightly toxic upon acute oral ingestion i.e. Acute toxic Class IV (oral) in accordance with CLP Regulation. Since no data for acute dermal and inhalation toxicity are available and the physical chemical properties of the substance demonstrate a very low vapour pressure as well as a negligible low skin penetration rate, the substance will not be classified for acute dermal or inhalation toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.